from Reuters: Top News https://ift.tt/2ICTgHV Roche Holding AG is to buy U.S.-based Spark Therapeutics in a $4.3 billion deal that will give the Swiss drugmaker a foothold in gene therapy.
Roche bets $4.3 billion on Spark in gene therapy move
Roche Holding AG is to buy U.S.-based Spark Therapeutics in a $4.3 billion deal that will give the Swiss drugmaker a foothold in gene therapy.

from Reuters: Top News https://ift.tt/2ICTgHV Roche Holding AG is to buy U.S.-based Spark Therapeutics in a $4.3 billion deal that will give the Swiss drugmaker a foothold in gene therapy.
from Reuters: Top News https://ift.tt/2ICTgHV Roche Holding AG is to buy U.S.-based Spark Therapeutics in a $4.3 billion deal that will give the Swiss drugmaker a foothold in gene therapy.
Related Posts:
China rebuffs Germany's call for U.S. missile deal with RussiaChina rejected on Saturday German Chancellor Angela Merkel's appeal to join a Cold War-era arms control treaty that the United States accuses Russia o… Read More
More U.S. aid for Venezuela touches down amid distribution uncertaintyA U.S. military transport plane carrying humanitarian aid meant for Venezuelans landed on Saturday in the Colombian border city of Cucuta, where food … Read More
French police fire tear gas as latest 'yellow vest' protests turn violentFrench police fired tear gas to disperse protesters who threw projectiles and set bins on fire in Paris, Lyon and Bordeaux on Saturday, as the 14th st… Read More
Pence chastises EU, rejects Merkel's call to work with RussiaU.S. Vice President Mike Pence rebuked European powers over Iran and Venezuela on Saturday in a renewed attack on Washington's traditional allies, rej… Read More
Canada's Freeland pushes end of steel, aluminum tariffs in meeting with PelosiCanadian Foreign Minister Chrystia Freeland said on Saturday she had made clear in a meeting with U.S. House of Representatives Speaker Nancy Pelosi a… Read More
0 comments:
Post a Comment